9999999997-17-001536.txt : 20170302
9999999997-17-001536.hdr.sgml : 20170302
20170302135843
ACCESSION NUMBER: 9999999997-17-001536
CONFORMED SUBMISSION TYPE: CT ORDER
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20170302
DATE AS OF CHANGE: 20170302
20170302
20170302
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGENUS INC
CENTRAL INDEX KEY: 0001098972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 061562417
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: CT ORDER
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29089
FILM NUMBER: 17658045
BUSINESS ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-674-4410
MAIL ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIGENICS INC /DE/
DATE OF NAME CHANGE: 19991115
CT ORDER
1
filename1.pdf
begin 644 filename1.pdf
M)5!$1BTQ+C4-)>+CS],-"C$P(# @;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S
M=')E86T-96YD;V)J#7-T87)T>')E9@T*, T*)25%3T8-"B @(" @(" @#0HR
M,B P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22 X-"],(#8X+TQE;F=T
M:" V,2]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G (.&094P C$+ P<#7!E+T-A=&%L;V<^/@UE;F1O8FH-,3(@
M,"!O8FH-/#PO0V]N=&5N=',@,30@,"!2+T-R;W!";WA;," P(#8Q,B W.3)=
M+TUE9&EA0F]X6S @," V,3(@-SDR72]087)E;G0@." P(%(O4F5S;W5R8V5S
M(#$V(# @4B]2;W1A=&4@,"]4>7!E+U!A9V4^/@UE;F1O8FH-,3,@,"!O8FH-
M/#PO1FEL=&5R+T9L871E1&5C;V1E+T9II)/K:]LP$,#_E?NX?S&8GK2AM?FG(L-CYC
MVDH77C=UEBB](>N;F*3JI+>SF4G_L89?LFB5,9; 2#+O/I,ET"^4D_3EJ"X]
M27UT<5L[;S-5:8BFC%S+XU>5[P\:YZ3D1KG0A+.0Q(7[0L%E"1:E3_-[QRZ^V$NCMSD
M1UTWY'%P%7O1A6P5YKS5_K;*ZEU>[$ !):!.#P5CGN>!R\&,\1K[7XO@
MO-MQA:& D#'#7V27%TUM%OJGON_R1'2N#(+0QMPI]*Q[SF%K>
MG>4T>OH),<]U-][M1]$+7Z-'Q?O0^R=U_AO41?QCT+V7-TY'O''V'[Q=! G#
M]7?BQHRAU;_PD#=+64<-TH;O?N[2$1=U^E+ALL:$702)P8Y#C2?V,PU90X;'
M_Y.^.Q_$+./.-@S^$6 X'J%. T*96YDT&!*DA$4ISAS)DSAWEWNY:P:P%C""]<2OIK]<#;R22Y+3-$[XO$_+C
M!B^#S^S3:IG.N1>*A-W FGN1B%G*A633U*[.W2+PO]+?!MY8Q'%TZ=,?.Y\T
M()_K^>S3PS)=+Z>^0/LRGZ1U.'%AH
M.(Z^SF'^?0HX4XS1TZ,)VE<+\ F8P(_("%SB$6(HQ^G*N,1!A?I=H'
MZ^";[E1U:&%9Y<*8!"(:_02\\05V;*%+!:M:@.\%B3]!Y],>-L]\(D9,
M=YTJ(*L@V^]+G6>=KGDD(E;!H2I4 P\'3",(-UX C?IR,-]4V^EJ1T;JM5-5
MJ^L*ZJW%'3N*PI!'*DH;1@;[1GW5-0:P0R>2-1SC3EA6=62;U]56%ZKJ=%9"
MUZBL>^8Q?L85V-:66LCXR%*+TCN>(-T)#>AJ6S>4%KKM*"C=@>+4F:\<,6)Y
M>2@PV2TNF?/Q0\W'.'[FV/X,NB<%\]]3*
M$_8';)$ !6 4=]D;)*8) \&ECQP]0G5-HA^AYXK(/F2M]=DHA+-%=$RB+6S>
MP)9W:.IK 4M$-#D!UOMT,6.V&0(Q81T5(J Y'S/=$HH\1& 0(L)RXK#\'#;9G^7:*EMQ>JI$)U5PLK-!M7M:M
MPA80@&GF=5-@SY9O0ZM^R,+X+*I3IJY4ZM4UR[$#?P48 #O-NFX-"F5N9'-T,E,P4#!7,+10L+'1
M]RO-+8X&<0T4@F+M[( BP?HN=G8 08 C84(-PT*96YDFMC.60B/SX*/'@Z>&UP;65T82!X;6QN#IX;7!T:STB061O8F4@6$U0($-O"UN&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(@H@(" @
M(" @(" @("!X;6QN&UL.FQA;F<](G@M
M9&5F875L="(^36EC&UP.D-R96%T941A=&4^,C Q-RTP,RTP,E0Q,3HU-CHU,2TP-3HP
M,#PO>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX;7 Z0W)E871O&UP34TZ26YS=&%N8V5)1#YU=6ED.F%A-65F-S0Q+38T
M,3 M-&,V82TX86,Q+3EC9C%E9C4T,&)B-CPO>&UP34TZ26YS=&%N8V5)1#X*
M(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(#POJ'5!:DZ@?(RQ"L(P% !_Y6TF@VF2&D410>Q:*"AV<:E-Q&CH
MDY0G_:R2=<>1XHN=\BG!.5 N)3AEE955B_[_I"/T[S&0V(^$UX&AB9EC
M2H' &*7A(OHX>?SDBY35*7(*HHU%S7ACZ)$\S*%>K$RM"@>2N]U7@ $ $N0_
MCPT*96YD7!E+UA2968O5ULQ(#(@,5T^/G-T
M')E9@T*,3$V#0HE
&)45/1@T*
end